Chunsheng Gao Selected Research

Chunsheng Gao Research Topics

Disease

15	Neoplasms (Cancer) 03/2022 - 07/2012
9	Glioma (Gliomas) 12/2021 - 11/2018
5	Alzheimer Disease (Alzheimer's Disease) 08/2023 - 01/2020
5	Nasopharyngeal Carcinoma 03/2022 - 03/2014
4	Mitochondrial Diseases (Mitochondrial Disease) 01/2022 - 01/2020
3	Traumatic Brain Injuries (Traumatic Brain Injury) 03/2024 - 01/2022
3	Heavy Metal Poisoning 04/2023 - 12/2021
3	Neoplasm Metastasis (Metastasis) 11/2021 - 03/2014
3	Allergic Rhinitis 02/2015 - 12/2007
1	Gliosis 03/2024
1	Bacterial Pneumonia 12/2022
1	Lead Poisoning (Poisoning, Lead) 11/2022
1	Gout 10/2022
1	Drug-Related Side Effects and Adverse Reactions 10/2022
1	Acute Lung Injury 08/2022
1	Pathologic Constriction (Stenosis) 07/2022
1	COVID-19 05/2022
1	Lung Injury 01/2022
1	Occupational Diseases (Occupational Disease) 12/2021
1	Inflammation (Inflammations) 12/2021
1	Pneumonia (Pneumonitis) 12/2021
1	Poisoning 12/2021
1	Osteosarcoma (Osteogenic Sarcoma) 01/2021
1	Skeletal Abnormalities Mandibular Hypoplasia Auditory Canal Atresia Short Stature 11/2020
1	Brain Neoplasms (Brain Tumor) 01/2019
1	Smallpox (Variola) 01/2017

Drug/Important Bio-Agent (IBA)

7	Peptides (Polypeptides)IBA 03/2024 - 11/2018
6	LigandsIBA 12/2021 - 11/2018
4	Proteins (Proteins, Gene)FDA Link 03/2022 - 08/2015
4	LipidsIBA 12/2021 - 11/2018
4	Transferrin Receptors (Transferrin Receptor)IBA 01/2019 - 11/2018
3	CurcuminIBA 08/2023 - 01/2020
3	Messenger RNA (mRNA)IBA 03/2022 - 03/2014
2	AntidotesIBA 04/2023 - 11/2022
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 02/2023 - 01/2022
2	Succimer (Dimercaptosuccinic Acid)FDA Link 11/2022 - 12/2021
2	cepharanthineIBA 08/2022 - 12/2021
2	Liposomes (Liposome)IBA 03/2022 - 01/2019
2	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 03/2022 - 07/2021
2	CytokinesIBA 01/2022 - 12/2021
2	Nanoparticle Drug Delivery SystemIBA 12/2021 - 11/2021
2	asparagine-glycine-arginineIBA 12/2021 - 01/2019
2	homocamptothecinIBA 08/2021 - 11/2018
2	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2021 - 12/2020
2	MicroRNAs (MicroRNA)IBA 01/2021 - 11/2018
2	EnzymesIBA 11/2020 - 08/2015
2	Vincristine (Oncovin)FDA LinkGeneric 11/2018 - 11/2018
2	Phosphofructokinase-1 (Phosphofructokinase 1)IBA 08/2015 - 03/2014
1	Polypyrimidine Tract-Binding ProteinIBA 03/2024
1	Glial Fibrillary Acidic ProteinIBA 03/2024
1	LipopeptidesIBA 12/2022
1	4- (4- dihexadecylaminostyryl)- N- methylpyridium (DiA)IBA 10/2022
1	Colchicine FDA LinkGeneric 10/2022
1	Antiviral Agents (Antivirals)IBA 05/2022
1	Ivermectin (Mectizan)FDA Link 05/2022
1	Cell-Penetrating PeptidesIBA 03/2022
1	cyclic arginine-glycine-aspartic acid peptideIBA 03/2022
1	Small Interfering RNA (siRNA)IBA 03/2022
1	Mitochondrial DNA (mtDNA)IBA 01/2022
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2022
1	olaparibIBA 01/2022
1	Interleukin-6 (Interleukin 6)IBA 01/2022
1	LipopolysaccharidesIBA 01/2022
1	2-aminoethylmethacrylate (AEM)IBA 12/2021
1	SolutionsIBA 12/2021
1	ChromiumIBA 12/2021
1	2-aminoethylmethyl sulfoneIBA 12/2021
1	AntigensIBA 11/2021
1	Neoplasm Antigens (Tumor Antigens)IBA 11/2021
1	MicellesIBA 11/2021
1	Caveolin 1IBA 01/2021
1	Albumin-Bound Paclitaxel FDA Link 01/2021
1	ResveratrolIBA 12/2020
1	FumonisinsIBA 11/2020
1	MycotoxinsIBA 11/2020
1	safingol (sphinganine)IBA 11/2020
1	SphingolipidsIBA 11/2020
1	CeramidesIBA 11/2020
1	Antineoplastic Agents (Antineoplastics)IBA 01/2019
1	Lipid Bilayers (Lipid Bilayer)IBA 01/2019
1	LDL Lipoproteins (beta Lipoproteins)IBA 11/2018
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 11/2018
1	ApoferritinsIBA 11/2018
1	LDL Receptors (LDL Receptor)IBA 11/2018
1	Heparan Sulfate Proteoglycans (Heparan Sulfate Proteoglycan)IBA 11/2018
1	tumstatin (74-98)IBA 11/2018
1	HDL LipoproteinsIBA 11/2018
1	10-hydroxycamptothecinIBA 11/2018
1	oxidized low density lipoproteinIBA 11/2018
1	Cisplatin (Platino)FDA LinkGeneric 01/2017
1	tecovirimatIBA 01/2017
1	CyclodextrinsIBA 01/2017

Therapy/Procedure

12	Therapeutics 03/2022 - 12/2007
3	Drug Therapy (Chemotherapy) 12/2021 - 11/2018
1	Chelation Therapy (Therapy, Chelation) 11/2022
1	Myringoplasty 07/2022
1	Oral Administration 05/2022
1	Induced Hyperthermia (Thermotherapy) 03/2022
1	Aftercare (After-Treatment) 03/2022
1	Immunotherapy 11/2021